HAV, HBV, HCV and HIV seroprevalence in patients who requested ELISA examination in the emergency department, a retrospective study.

Seroprevelance of patients in Emergency Departments

Abstract

Introduction

The aim of this study is to determine the seroprevalence of HAV, HBV, HCV and HIV in patients who applied to the emergency service for hepatitis viruses and HIV serology, to examine their correlation with their admission complaints, and to document the incidence of positivity in the community cross-sectionally by determining the proportion of risky patients who applied to the emergency department

Material Method

Among the patients who applied to the emergency department between January 2022 and December 2022, anti-HAV IgM, HBsAg, anti-HBc IgM, HIV Ag/Ab (antigen/antibody) (HIV-1/ HIV-2 IgM and IgG antibodies and HIV-1 antibodies) cases that were requested to be tested for p24 antigen) were included in the study

Results

General characteristics of the patients, Viral markers measured by ELISA method and their distribution by gender, Viral markers measured by ELISA method and their distribution by nationality and Leading search reasons in serology examinations were evaluated.

Conclusions

This study has data that can reflect the society in terms of the place where it was conducted and the number of patients included in the study. With the sensitivity of the Ministry of Health on the subject and the impact of the intensive work of the primary care on vaccination, we have found satisfactory results in terms of transmission and vaccination.